本页面由Tiger Trade Technology Pte. Ltd.提供服务

Benitec Biopharma Limited

11.39
-0.6900-5.71%
成交量:16.90万
成交额:193.08万
市值:3.90亿
市盈率:-12.20
高:12.12
开:12.11
低:11.08
收:12.08
52周最高:16.76
52周最低:9.85
股本:3,425.49万
流通股本:1,792.50万
量比:2.32
换手率:0.94%
股息:- -
股息率:- -
每股收益(TTM):-0.9338
每股收益(LYR):-1.0472
净资产收益率:-29.58%
总资产收益率:-19.93%
市净率:2.13
市盈率(LYR):-10.88

数据加载中...

2023/08/11

重要事件披露

Form 8-K - Current report
2023/08/10

重要事件披露

Form 8-K - Current report
2023/08/07

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/08/03

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/08/03

SEC问询函

Form CORRESP - Correspondence
2023/08/03

SEC问询函

Form CORRESP - Correspondence
2023/07/31

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/07/26

重要事件披露

Form 8-K - Current report
2023/07/07

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/06/26

重要事件披露

Form 8-K - Current report
2023/06/15

重要事件披露

Form 8-K - Current report
2023/05/15

重要事件披露

Form 8-K - Current report
2023/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/18

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/03/08

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/02/13

重要事件披露

8-K - Current report
2023/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals